Cargando...
[−2 ] PRO-PSA IS MORE ACCURATE THAN TOTAL AND FREE PSA IN DIFFERENTIATING PROSTATE CANCER FROM BENIGN DISEASE IN A PROSPECTIVE PROSTATE CANCER SCREENING STUDY,
PURPOSE: Due to the limited specificity of prostate-specific antigen (PSA) for prostate cancer (CaP) screening, there is an ongoing search for adjunctive biomarkers. Retrospective studies have suggested that an isoform of proenzyme PSA called [−2] proPSA (p2PSA) may enhance the specificity of PSA-ba...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3537165/ https://ncbi.nlm.nih.gov/pubmed/20171670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.12.056 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|